[HTML][HTML] Epicardial epithelial-to-mesenchymal transition in heart development and disease

M Krainock, O Toubat, S Danopoulos… - Journal of clinical …, 2016 - mdpi.com
The epicardium is an epithelial monolayer that plays a central role in heart development and
the myocardial response to injury. Recent developments in our understanding of epicardial …

Recent advancements in understanding endogenous heart regeneration—insights from adult zebrafish and neonatal mice

N Rubin, MR Harrison, M Krainock, R Kim… - Seminars in cell & …, 2016 - Elsevier
Enhancing the endogenous regenerative capacity of the mammalian heart is a promising
strategy that can lead to potential treatment of injured cardiac tissues. Studies on heart …

[HTML][HTML] Circulating tumor DNA monitoring on chemo-immunotherapy for risk stratification in advanced non–small cell lung cancer

B Pellini, RW Madison, MA Childress, ST Miller… - Clinical Cancer …, 2023 - AACR
Purpose: Chemoimmunotherapy (chemoIO) is a prevalent first-line treatment for advanced
driver-negative non–small cell lung cancer (NSCLC), with maintenance therapy given after …

[HTML][HTML] Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient …

PM Kasi, G Budde, M Krainock, VN Aushev… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors have shown great promise in treating patients with mismatch
repair deficient/microsatellite instability high (dMMR/MSI-H) colorectal cancer (CRC) …

[HTML][HTML] ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

ES Lebow, N Shaverdian, JE Eichholz… - Frontiers in …, 2023 - frontiersin.org
Background Sensitive and reliable biomarkers for early detection of recurrence are needed
to improve post-definitive radiation risk stratification, disease management, and outcomes …

BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours

PM Kasi, S Chakrabarti, S Sawyer, M Krainock… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Immunotherapy (IO) has transformed the treatment paradigm for a wide variety
of solid tumours. However, assessment of response can be challenging with conventional …

Rac1 modulates mammalian lung branching morphogenesis in part through canonical Wnt signaling

S Danopoulos, M Krainock, O Toubat… - … of Physiology-Lung …, 2016 - journals.physiology.org
Lung branching morphogenesis relies on a number of factors, including proper epithelial
cell proliferation and differentiation, cell polarity, and migration. Rac1, a small Rho GTPase …

[HTML][HTML] Early detection of circulating tumor DNA postoperatively enables discovery of resectable metastatic disease in a patient with colon cancer

BA Weinberg, ER Winslow, M Bayasi… - Case Reports in …, 2022 - karger.com
Currently, serum carcinoembryonic agent (CEA) along with contrast-enhanced imaging and
colonoscopy are used for evaluation of recurrence of colorectal cancer. However, CEA is an …

Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments

Y Oh, SM Yoon, J Lee, JH Park, S Lee, T Hong… - Thoracic …, 2024 - Wiley Online Library
Abstract Background Circulating tumor DNA (ctDNA) has emerged as a prognostic and
predictive biomarker for detection of minimal residual disease (MRD), monitoring treatment …

[HTML][HTML] Protocol: BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with …

PM Kasi, S Chakrabarti, S Sawyer, M Krainock… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Introduction Immunotherapy (IO) has transformed the treatment paradigm for a wide variety
of solid tumours. However, assessment of response can be challenging with conventional …